SciSparc Ltd. (NASDAQ: SPRC) stock is surging on Thursday, with a session volume of 58.21 million compared to the average volume of 2.49 million as per data from Benzinga Pro. SPRC stock is racing ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
SciSparc Ltd. (NASDAQ:SPRC) (“SciSparc”) is a specialty clinical-stage pharmaceutical company focusing on creating and enhancing a portfolio of technologies and assets based on cannabinoid ...
SciSparc Ltd. SPRC signed a definitive agreement with Merhavit M.R.M Holding and Management Ltd (“M.R.M”), to acquire its rights to purchase, Wellution, an Amazon.com AMZN Marketplace account, ...
SciSparc (NASDAQ: SPRC) stock will rise 2,600% today. SPRC stock rising 26x is not the result of some breakthrough in clinical trials. It’s a purely technical move. It’s also a change only in the ...
Shares of drug discovery specialist SciSparc (NASDAQ:SPRC) are popping sharply today on encouraging clinical study results. Specifically, the company’s joint venture (JV) project MitoCareX Bio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results